ArticleFrontiers in neurology2011
Stepwise approach to myopathy in systemic disease.
Article in Frontiers in neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 77 citations in OpenAlex.
- Optoacoustic muscle imaging.Journal of neuromuscular diseases · 2026Review
- Classifying neurogenic dysphagia as a movement disorder.Brain : a journal of neurology · 2025Review
- The Broad Spectrum of Gallbladder Paraneoplastic Syndromes.Gastro hep advances · 2024Review
- DevelopingBiomedicines · 2023Article
- [Creatine phosphokinase enzyme elevation in two third-level hospitals of Córdoba].Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2022Article
- Exogenous Antioxidants in Remyelination and Skeletal Muscle Recovery.Biomedicines · 2022Review
- Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.BMC musculoskeletal disorders · 2022Article
- Association of acute hepatitis B and acute myopathy: a case report.Journal of medical case reports · 2022Article
- Proximal Myopathy With Hypercalcemic Crisis and Papillary Thyroid Carcinoma in a 38-Year-Old Female.Cureus · 2021Article
- Skeletal Muscle and Childhood Cancer: Where are we now and where we go from here.Aging and cancer · 2021Article
- Effect of vitamin E and alpha lipoic acid on intestinal development associated with wooden breast myopathy in broilers.Poultry science · 2021Article
- Carbimazole induced rhabdomyolysis.Endocrinology, diabetes & metabolism case reports · 2021Article
- A man with fever and bilateral limb weakness.Internal and emergency medicine · 2020Article
- Cross-Talk Between Extracellular Matrix and Skeletal Muscle: Implications for Myopathies.Frontiers in pharmacology · 2020Review
- Adiponectin in Myopathies.International journal of molecular sciences · 2019Review
- Drug-induced paraspinal myositis mimicking acute bilateral sciatica.BMJ case reports · 2019Article
- Sarcocystis myopathy in a patient with HIV-AIDS.Journal of neurovirology · 2018Article
- Pitting Oedema in a Patient with Lumbar Disc Herniation: Case report of an unusual association.Sultan Qaboos University medical journal · 2017Article
- Overexpression of miRNA-9 Generates Muscle Hypercontraction Through Translational Repression of Troponin-T inG3 (Bethesda, Md.) · 2017Article
- Myositis Mimics.Current rheumatology reports · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Muscle diseases can constitute a large variety of both acquired and hereditary disorders. Myopathies in systemic disease results from several different disease processes including endocrine, inflammatory, paraneoplastic, infectious, drug- and toxin-induced, critical illness myopathy, metabolic, and myopathies with other systemic disorders. Patients with systemic myopathies often present acutely or sub acutely. On the other hand, familial myopathies or dystrophies generally present in a chronic fashion with exceptions of metabolic myopathies where symptoms on occasion can be precipitated acutely. Most of the inflammatory myopathies can have a chance association with malignant lesions; the incidence appears to be specifically increased only in patients with dermatomyositis. In dealing with myopathies associated with systemic illnesses, the focus will be on the acquired causes. Management is beyond the scope of this chapter. Prognosis is based upon the underlying cause and, most of the time, carries a good prognosis. In order to approach a patient with suspected myopathy from systemic disease, a stepwise approach is utilized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.